Abstract:Alzheimer's disease (AD) is the most common form of dementia. Populations migrating from developing to industrialized countries seem to elicit a higher incidence and prevalence rate of AD, suggesting lifestyle and environmental factors to have a role in the pathophysiology of AD. One of its major neuropathological hallmarks is the deposition of Aβ peptides as amyloid plaques in the brain of AD patients. Aβ is proteolytically cleaved out of the larger amyloid precursor protein (APP). Cu and Mn are often found in drinking water and may have a neurotoxic potential. APP is involved in Cu homeostasis in mouse and man. In vitro observations and in vivo data obtained from APP mouse models provide strong evidence that APP overexpression enables intracellular Cu to be transported out of the cell. Disturbed metal‐ion homeostasis with elevated serum Cu levels occurs in Alzheimer and Down's patients and lowered levels in post‐mortem AD brain. We observed that bioavailable Cu has specific beneficial effects in an Alzheimer's disease mouse model. This should be regarded as a proof‐of‐concept for a prophylactic approach to overcome the observed CNS Cu deficiency in the brain of Alzheimer's disease patients. Manganism is a disorder with symptoms similar to that of Parkinson's disease. The precise mechanism how manganese can damage the nervous system is unknown. There is some evidence that iron and manganese may utilize similar transport systems. Epidemi ologic data strongly suggests that manganese enters the body primarily via inhalation and through the ingestion of manganese in drinking water. Kupfer und Mangan aus der Umwelt und die Pathophysiologie neurologischer Erkrankungen (Alzheimer‐Krankheit und Manganismus) Die Alzheimer‐Krankheit (AD) ist die häufigste Form der Altersdemenz. In Bevölkerungsgruppen, die aus Entwicklungs‐ in industrialisierte Länder übersiedeln, steigen parallel dazu absolute und relative Häufigkeit der AD. Lebensweise und Umwelt scheinen demnach die Pathophysiologie der AD zu beeinflussen. Eines ihrer wichtigsten Merkmale ist die Ablagerung von Aβ‐Peptiden in Form von Amyloidplatten im Gehirn. Das Aβ‐Peptid entsteht proteolytisch aus einem größeren Vorläufermolekül, dem Amyloid‐precursor protein (APP). Cu und Mn kommen oft im Trinkwasser vor und könnten beide ein neurotoxisches Potential besitzen. APP ist in den Stoffwechsel von Cu in Maus und Mensch eingebunden. Beobachtungen in vitro und In‐vivo‐Daten aus Mausmodellen belegen zweifelsfrei, dass die Überexpression von APP dem Cu das Verlassen der Zelle ermöglicht. In Patienten mit AD oder dem Down‐Syndrom sind infolge Störung der Metall‐Homöostase die Cu‐Werte im Serum erhöht und im Gehirn verstorbener AD‐Patienten erniedrigt. Wir selbst beobachteten, dass bioverfügbares Cu im Mausmodell Entstehung und Verlauf der AD mildert. Dies ist ein vielversprechender Ausgangspunkt für die Suche nach Möglichkeiten, die Cu‐Verarmung bestimmter Gehirnbereiche von AD‐Patienten prophylaktisch zu unterlaufen. Der genaue Mechanismus, nach dem Mn das Gehirn schädigen kann, ist unbekannt. Es erreicht den Körper vermutlich unter Nutzung der Transportsysteme für Fe vor allem per Inhalation und auf dem Trinkwasserpfad. Die Symptomatik des Manganismus ähnelt derjenigen des Parkinsonismus.

High manganese, a risk for Alzheimer's disease: high manganese induces amyloid-β related cognitive impairment.

Oxidative Stress Markers and Metal Ions Are Correlated with Cognitive Function in Alzheimer’s Disease

High level of Mn in brain is a risk for Alzheimer disease.

Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation

The Gut Microbiota Confers Protection in the CNS Against Neurodegeneration Induced by Manganism

Manganese level and cognitive decline in older adults with the APOE e4 allele: a preliminary study

Manganese induces oxidative damage in the hippocampus by regulating the expression of oxidative stress‐related genes via modulation of H3K18 acetylation

Magnesium modulates amyloid-beta protein precursor trafficking and processing.

Manganese exposure leads to depressive-like behavior through disruption of the Gln-Glu-GABA metabolic cycle

The impact of manganese on vascular endothelium

Self-assembly Hollow Manganese Prussian White Nanocapsules Attenuate Tau-related Neuropathology and Cognitive Decline.

The Gut Microbiota Attenuate Neuroinflammation in Manganese Exposure by Inhibiting Cerebral NLRP3 Inflammasome

Metal Exposure and Alzheimer's Pathogenesis.

Distinct regional vulnerability to Aβ and iron accumulation in post mortem AD brains

Manganese Causes Neurotoxic Iron Accumulation Via Translational Repression of Amyloid Precursor Protein and H‐Ferritin

Environmental Copper and Manganese in the Pathophysiology of Neurologic Diseases (Alzheimer's Disease and Manganism)

Current understanding of metal ions in the pathogenesis of Alzheimer’s disease

Manganese-induced α-synuclein overexpression promotes the accumulation of dysfunctional synaptic vesicles and hippocampal synaptotoxicity by suppressing Rab26-dependent autophagy in presynaptic neurons

Signal Transduction Associated with Mn-induced Neurological Dysfunction

Metals homeostasis and related proteins in alzheimer's disease

Effect of metal ions on Alzheimer's disease